BackCartesian Therapeutics Overview
Cartesian Therapeutics Inc

Cartesian Therapeutics Target Price

Analysts' 12-month price predictions for RNAC.

Get informed when a big investor buys or sells

+ Follow

Share Price

$6.27

Average Target Price

$20.50227.2% upside

2 analysts in the last 4 months

High: $25 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-12H.C. Wainwright$25299% upsideOpen
2026-03-09Cantor Fitzgerald$16155.4% upsideOpen
2024-08-09H.C. WainwrightMitchell Kapoor$45618.3% upsideOpen
2024-07-03Canaccord GenuityJohn Newman$43586.4% upsideOpen
2024-05-24Mizuho SecuritiesUy Ear$40538.5% upsideOpen